Cancer Treatment Protocols Expert

NTU International A/S; Manama; On-site; BHD 34,000 - 49,000; Full time

Job summary

NTU International A/S seeks a highly experienced Key Expert – Cancer Treatment Protocols Expert to lead harmonisation and implementation of evidence-based systemic anti-cancer therapy protocols for the Syrian Ministry of Health project.

You will oversee development of chemotherapy protocols, pharmacovigilance, and safety practices, while coordinating with clinical stakeholders and training teams across centres in challenging settings.

Qualifications

• Minimum 10 years of clinical or technical experience in medical oncology, including development or revision of national or institutional protocols for chemotherapy.
• Familiarity with international guidelines (WHO EML for cancer, NCCN, ESMO) and adapting them to resource-limited systems.
• Experience strengthening pharmacovigilance and medication-safety systems for chemotherapy.
• Experience designing structured clinical training for oncology teams on protocol implementation and toxicity management.
• Experience developing monitoring tools to track adherence and outcomes across multiple centres.

Responsibilities

• Develop, harmonise and implement evidence-based cancer treatment protocols including chemotherapy.
• Strengthen pharmacovigilance and safety systems for cancer medicines.
• Facilitate consensus among clinicians on standardized pathways.
• Design training programmes for physicians, pharmacists and nurses.

Skills

Harmonise protocols

Stakeholder consensus

Pharmacovigilance

Treatment pathways

Clinical training

Education

Medical degree with board certification (Clinical Oncology / Medical Oncology / Haematology-Oncology / Clinical Pharmacology)

Master's in Public Health (asset)

Job description

Key Expert – Cancer Treatment Protocols Expert (Cat. II)

Project: Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.

Indicative Start Date: 9 December 2026

Implementation Period: 14 months (indicative end date: 9 February 2028)

NTU International is currently identifying qualified experts for the EU-funded project “Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.”

The assignment aims to support the institutional strengthening and governance capacities of the Syrian Ministry of Health, contributing to more effective institutional performance, evidence-based decision-making, accountability and sustainable capacity development.

In this context, we are seeking a highly qualified Key Expert – Cancer Treatment Protocols Expert (Cat. II) to provide strategic and technical assistance in the development, harmonisation and implementation of evidence-based systemic anti-cancer therapy protocols, with particular emphasis on chemotherapy, medication safety, pharmacovigilance and clinical quality assurance.

Qualifications and Skills Required

• Medical degree with board certification or equivalent specialisation in Clinical Oncology, Medical Oncology, Haematology-Oncology or Clinical Pharmacology.
• A Master's degree in Public Health or a related field is considered an asset.
• Strong capacity to harmonise cancer treatment practices across geographically dispersed and unevenly resourced oncology centres.
• Sound understanding of pharmaceutical supply-chain and quality-assurance considerations affecting essential cancer medicines.
• Ability to facilitate consensus-building among clinical stakeholders on standardised, evidence-based treatment pathways.
• Prior experience supporting ministries of health or national cancer-control programmes in post-conflict or early-recovery contexts is strongly preferred.

General Professional Experience

• Minimum 10 years of clinical or technical experience in medical oncology, including substantial direct experience in the development, harmonisation or revision of national or institutional systemic anti-cancer therapy protocols, particularly chemotherapy protocols.

Specific Professional Experience

• Demonstrated familiarity with current international treatment guidelines (e.g. WHO Essential Medicines List for cancer, NCCN, ESMO) and their contextual adaptation to resource-constrained or fragile health systems.
• Proven experience developing or strengthening pharmacovigilance and medication-safety systems specific to chemotherapy administration, including adverse-event reporting, dose-verification protocols and safe-handling procedures.
• Experience designing structured clinical training programmes for oncology teams (physicians, pharmacists and nursing staff) on protocol implementation, treatment sequencing and toxicity management.
• Experience developing monitoring and evaluation tools to track treatment adherence,clinical outcomes and protocol-related safety indicators across multiple oncology centres.

Language Requirements

• English: Excellent written and spoken command – mandatory.
• Arabic: Working knowledge is considered a strong asset.